Health Technology

Nomi Health Acquires Everyone Health, Sano Surgery

Nomi Health


Everyone Health has agreements with self-funded employers and third-party administrators for pre-negotiated, all-inclusive prices that save employers up to 70% relative to commercial fee-for-service rates. The company delivers these savings via Sano Surgery’s direct contracting with more than 10,000 physicians and facilities — surgical hospitals, ambulatory surgery centers, endoscopy centers, radiology centers, labs and more — in 300 of the largest U.S. cities across 48 states, all now part of Nomi Health’s national provider network.

Nomi Health believes healthcare needs a rebuild, not a renovation. These companies share in our vision of extracting the complexity and cost from traditional healthcare, so buyers experience substantial savings and, most importantly, patients have greater access to more affordable care. In three short years, we expanded easy access to care to 15 million Americans, while significantly driving down cost of care to buyers. The immediate contributions of Everyone Health and Sano Surgery will accelerate this track record in the years ahead.”

Mark Newman, founder and CEO of Nomi Health

Founded by CEO Dutch Rojas 10 years ago, Sano Surgery has a network of nearly 6,000 medical facilities and 8,000 lab locations nationwide, ranging from radiology and orthopedics to women's health and oncology. This network enables Everyone Health to deliver higher quality medical treatments and services at lower prices. As a result, physicians benefit from predictable volumes and payments, while patients enjoy a more streamlined care and billing experience.

“My goal is affordable and accessible healthcare for all. We’ve built a nationwide network of physicians and medical facilities that allows us to bring substantially lower pricing and more transparent transactions to the market, benefiting countless Americans,” said Rojas, founder and CEO of Sano Surgery and Everyone Health. “As the dual crisis of access and affordability grows on the heels of the pandemic, the time is right to increase our impact as part of Nomi Health.”

The acquisitions enable buyers to turn to Nomi Health for a full suite of solutions — analytics, care delivery and a direct network — all underpinned by a modern claims infrastructure and payment rails. It also brings 12 full-time employees, including Rojas, to Nomi Health to accelerate the continued expansion of the company’s network of clinical partners, which is critical as Nomi Health takes its support and services into more communities nationwide.

The acquisitions of Everyone Health and Sano Surgery come on the heels of Nomi’s $200 million acquisition of healthcare analytics leader Artemis Health in January.

About Nomi Health
Nomi Health is a nationwide direct healthcare system making it easier than ever for any buyer of healthcare to access the highest quality affordable care for their communities. The company’s direct care ecosystem encompasses a real-time operating and payment system — inclusive of analytics and payment rails — as well as an integrated care delivery infrastructure featuring essential care services, pharmacy and an open network. To date, Nomi Health has saved buyers of care an average of 30 percent compared to traditional healthcare costs, while enabling them to give their communities more access to lower cost, high quality care.

From rural counties to some of the largest cities in America, Nomi Health has administered everyday healthcare services to more than 14 million Americans and counting in hundreds of communities nationwide. During COVID-19, this direct care model played a pivotal role in care access, public health and keeping economies open and operating.

Based in Orem, Utah, Nomi Health employs more than 2,000 nationwide, working to lower healthcare expenses, widen care access and improve the patient experience. The company is led by an experienced, cross-functional leadership team with clinical, healthcare, technology and finance backgrounds. Nomi Health has so far invested more than $10 million dollars in improving the well-being of the communities it serves. 

Spotlight

Spotlight

Related News

Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

PR Newswire | November 03, 2023

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring. "Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont." By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes. Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch. [Source: PR Newswire] Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives. ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days. DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities. The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring. The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable. DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion. As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37. DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance. Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.

Read More

Health Technology

Omega Healthcare with Tech Solutions Elevates Revenue Cycles

Omega Healthcare | October 13, 2023

Omega Healthcare Launches Omega Digital Platform (ODP): Advanced technology-driven solutions designed to ease administrative burdens and improve financial performance for healthcare organizations. Leveraging artificial intelligence, robotic process automation, machine learning, bots, and natural language processing, ODP enhances efficiency and accuracy in revenue cycle functions. Achievements include over 95 percent accuracy in coding, a 30 percent decrease in accounts receivable days, a 10-20 percent improvement in collections, and a significant reduction in denial rates. Omega Healthcare has launched its Omega Digital Platform (ODP), featuring advanced technology-driven solutions to alleviate healthcare organizations' administrative burdens and enhance their financial performance. Leveraging its expertise in domains such as artificial intelligence, robotic process automation, machine learning, bots, and natural language processing, Omega Healthcare's innovative solutions are designed to boost efficiency and accuracy within critical revenue cycle functions significantly. By minimizing the need for extensive human intervention, clients can reallocate resources, elevate employee and patient satisfaction, and drive improved financial outcomes. Omega Healthcare, renowned for its partnership with provider organizations across the United States, empowers them to attain impressive results, including a reduction in coding costs with an accuracy rate exceeding 95 percent, a substantial 30 percent decrease in accounts receivable (A/R) days, a notable 10-20 percent improvement in collections, and a significant drop in denial rates. The PREDICT workflow engine, an integral part of the ODP, harnesses AI-driven solutions, incorporating advanced proprietary algorithms and comprehensive datasets. PREDICT equips clients to proactively address issues, averting potential challenges through its predictive capabilities, preventive measures, and intelligent task prioritization. Additionally, implementing an automated digital workforce through Robotic Process Automation (RPA) streamlines client operations, reducing the burden of repetitive tasks while enhancing precision. This optimization improves efficiency and liberates staff and healthcare providers to dedicate their efforts to more strategic responsibilities and direct patient engagement. The Omega Digital Platform (ODP) offers comprehensive Revenue Cycle Management Solutions that encompass Patient Access, Mid-Revenue Cycle, and Business Office functions, providing clients with the means to mitigate revenue leakage. In today's healthcare landscape, where denials and compliance regulations can pose substantial financial challenges, effective revenue cycle management (RCM) is paramount. With its cutting-edge claims management system and purpose-built technologies, Omega Healthcare equips organizations to optimize their revenue cycles. Whether supplementing existing processes or overseeing the entire revenue cycle, Omega Healthcare's solutions help prevent denials, enhance coding quality and compliance, and bolster cash flow. This significant development was unveiled at the American Health Information Management Association 2023 Annual Conference. Omega Healthcare is actively participating at AHIMA23 (Booth 311) and is co-presenting its successful utilization of technology in collaboration with physicians at a prominent regional hospital to enhance coding compliance and financial outcomes. This reflects Omega Healthcare's ongoing commitment to advancing healthcare operations and financial success.

Read More

Health Technology

GE HealthCare Rolls Out Vscan Air SL Ultrasound Device

GE HealthCare | September 06, 2023

GE HealthCare's latest release is poised to empower healthcare professionals with advanced diagnostic capabilities. Vscan Air SL aims to aid physicians in expediting the identification and treatment of illnesses. This portable, wireless ultrasound imaging device will revolutionize cardiac assessments, seamlessly integrating with diverse ultrasound technologies to enhance GE HealthCare's medical equipment. GE HealthCare has introduced Vscan Air SL, a state-of-the-art medical instrument engineered to enhance the efficiency of healthcare practitioners in diagnosing and treating diverse medical conditions. Due to its portability and wireless functionality, this device excels at conducting cardiac and vascular assessments directly at the patient's bedside. It leverages single-crystal transducer technology, setting a new standard for ultrasound imaging precision. By integrating GE HealthCare's SignalMax and XDclear innovations, Vscan Air SL ensures unparalleled image quality and diagnostic accuracy. This instrument aims to provide remarkable penetration levels, image clarity, and sensitivity, delivering a diagnostic experience of the utmost reliability. Vscan Air SL facilitates the swift acquisition and real-time analysis of high-quality cardiac and vascular images, empowering clinicians with timely insights at the point of care. With its ability to provide immediate, high-quality imaging, Vscan Air SL assists physicians in making well-informed decisions promptly, thereby enhancing patient care. Its intuitive design streamlines healthcare workflows, enabling quicker and more efficient treatment planning for needy patients. Vscan Air SL alleviates the strain on conventional imaging resources by offering on-the-spot diagnostic capabilities, ensuring that medical professionals can deliver care with greater agility and effectiveness. "Having ever more powerful handheld ultrasound is a game changer for patient care," said Guy Lloyd, M.D., FRCP, Consultant Cardiologist at Barts Heart Center, University College London Hospitals and Clinical Director for Cardiovascular Diagnostics and Investigations. GE HealthCare is at the forefront of innovation, working to elevate healthcare delivery standards. The company's intelligent devices, supported by advanced data analytics and harnessing artificial intelligence, profoundly impact millions, facilitating quicker and more informed clinical decisions for healthcare practitioners. By pushing the boundaries of medical technology and knowledge, the company is leaving an indelible mark on the healthcare industry, propelling it towards a future characterized by heightened precision, advanced digitization, and improved well-being for patients worldwide. GE HealthCare is a leader in precision care that harmonizes innovation with patient-focused technologies to enhance healthcare. Its commitment is directed toward providing integrated solutions that optimize hospital efficiency, elevate clinician effectiveness, refine therapeutic precision, and improve patient well-being. It aspires to make contributions to the healthcare sphere that transcend traditional limitations.

Read More